Showing results (231-240 of 410) with videos related to
Sort By:
Pageof 41
Frontiers in Neurology|March 27, 2020
The Influence of Baseline Alzheimer's Disease Severity on Cognitive Decline and CSF Biomarkers in the NILVAD TrialLaila Abdullah, Fiona Crawford, Magda Tsolaki, et al.Neuroradiology|January 17, 2012
Education increases reserve against Alzheimer's disease--evidence from structural MRI analysisYawu Liu, Valtteri Julkunen, Teemu Paajanen, et al.Journal of Alzheimer'S Disease : JAD|October 6, 2011
Combinatorial markers of mild cognitive impairment conversion to Alzheimer's disease--cytokines and MRI measures together predict disease progressionSimon J Furney, Deborah Kronenberg, Andrew Simmons, et al.Neurobiology of Aging|September 18, 2013
Evidence of altered phosphatidylcholine metabolism in Alzheimer's diseaseLuke Whiley, Arundhuti Sen, James Heaton, et al.Neurobiology of Aging|September 26, 2013
Alzheimer's disease susceptibility variants in the MS4A6A gene are associated with altered levels of MS4A6A expression in bloodPetroula Proitsi, Sang Hyuck Lee, Katie Lunnon, et al.Human Molecular Genetics|May 19, 2012
Identification of cis-regulatory variation influencing protein abundance levels in human plasmaAnbarasu Lourdusamy, Stephan Newhouse, Katie Lunnon, et al.Journal of Alzheimer'S Disease Reports|March 29, 2024
Discriminant Potential of the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in Greek Older Adults with Subjective Cognitive Decline and Mild Cognitive ImpairmentMarianna Tsatali, Despina Moraitou, Moses Gialaouzidis, et al.Neurobiology of Aging|May 8, 2010
Analysis of regional MRI volumes and thicknesses as predictors of conversion from mild cognitive impairment to Alzheimer's diseaseYawu Liu, Teemu Paajanen, Yi Zhang, et al.Neurobiology of Aging|August 18, 2009
Combination analysis of neuropsychological tests and structural MRI measures in differentiating AD, MCI and control groups--the AddNeuroMed studyYawu Liu, Teemu Paajanen, Yi Zhang, et al.CNS Neuroscience & Therapeutics|April 8, 2010
Drug profile: transdermal rivastigmine patch in the treatment of Alzheimer diseaseMurat Emre, Roberto Bernabei, Rafael Blesa, et al.Pageof 41